Antipsychotic medications are commonly prescribed in children and adults with ASD (Curtin, Jojic \& Bandini, 2014). But weight gain has been known to be one of the less desirable effects of these medications, increasing one's risk for overweight and obesity. Based on experience in Holland Bloorview's Nutrition Clinic, working with a dietitian to follow specific dietary advice, such as having more protein while keeping the amount of calories the same, may be a possible and useful way to limit weight gain. This study's objective is to evaluate the feasibility (study designs, methods, processes) and acceptability (client/family satisfaction, perceived effectiveness) of a controlled energy diet with elevated protein intake in children and youth with ASD who are currently taking prescribed atypical antipsychotic medication.
Age range
6 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Caloric and protein intake
Timeframe: At the time of study enrolment (week 0) and during week 10 of intervention implementation (week 10)
Pre- (at time of study enrolment) and post-intervention anthropometric measurements
Timeframe: Measured at the time of study enrolment (week 0) and after ten weeks of intervention (week 11), assessed up to 11 weeks
Pre- (at time of study enrolment) and post-intervention anthropometric measurements
Timeframe: Measured at the time of study enrolment (week 0) and after ten weeks of intervention (week 11), assessed up to 11 weeks
Pre- (at time of study enrolment) and post-intervention anthropometric measurements
Timeframe: Measured at the time of study enrolment (week 0) and after ten weeks of following the intervention (week 11), assessed up to 11 weeks
Post-intervention interview with participants and family
Timeframe: Interview (anticipated duration of 60 minutes) will be conducted after week ten of intervention implementation (week 11)
Study feasibility (designs, methods, processes)
Timeframe: During the screening and recruitment process (anticipated duration of 1-1.5 months)
Study feasibility (designs, methods, processes)
Timeframe: Measurements taken at the start of the study during enrolment and at study completion (anticipated duration of 5 months)
Study feasibility (designs, methods, processes)
Timeframe: Measured at the time of study enrolment (week 0) and after ten weeks of intervention (week 11), assessed up to 11 weeks
Study feasibility (designs, methods, processes)
Timeframe: Interview (anticipated duration of 60 minutes) will be conducted after week ten of intervention implementation (week 11)
Study feasibility (designs, methods, processes)
Timeframe: Interview (anticipated duration of 60 minutes) will be conducted after week ten of intervention implementation (week 11)
Study feasibility (designs, methods, processes)
Timeframe: Interview (anticipated duration of 60 minutes) will be conducted after week ten of intervention implementation (week 11)
Study feasibility (designs, methods, processes)
Timeframe: Interview (anticipated duration of 60 minutes) will be conducted after week ten of intervention implementation (week 11)